Effectiveness of Using Educational Modules Via Bedside Tablet in Newly Diagnosed Type 1 Diabetes
Sponsor: Hackensack Meridian Health
Terminated
Site resources
Other terminated trials from Hackensack Meridian Health
Other Type 1 Diabetes Mellitus trials with similar outcome
A NA clinical study on Type 1 Diabetes Mellitus, this trial is terminated or withdrawn. The trial is conducted by Hackensack Meridian Health and has accumulated 14 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
14 versions recorded-
Jan 2026 — Present [monthly]
Terminated NA
-
May 2025 — Jan 2026 [monthly]
Terminated NA
Status: Suspended → Terminated
-
Sep 2024 — May 2025 [monthly]
Suspended NA
-
Jul 2024 — Sep 2024 [monthly]
Suspended NA
-
Mar 2024 — Jul 2024 [monthly]
Suspended NA
▶ Show 9 earlier versions
-
Mar 2023 — Mar 2024 [monthly]
Suspended NA
-
Sep 2022 — Mar 2023 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jun 2022 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Jun 2022 [monthly]
Recruiting NA
-
Jan 2021 — Sep 2021 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
Sep 2019 — Sep 2020 [monthly]
Recruiting NA
-
Sep 2018 — Sep 2019 [monthly]
Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Recruiting NA
First recorded
Apr 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hackensack Meridian Health
- Verizon Foundation
For direct contact, visit the study record on ClinicalTrials.gov .